← Leaderboards
Michael G Carlson
Vanderbilt University
$592
Attributed
$592
Total exposure
6
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$592 · 6
By mechanism
M01$592 · 6
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- David Herlie Robertson$14,232,685
- Mark A Magnuson$75,018,827
- Stephen N. Davis$16,024,395
- Clare McCabe$2,222,891
- Maureen K Hahn$1,161,503
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchExerciseInsulinlike Growth FactorHuman Therapy EvaluationBody WeightDiabetes Mellitus TherapyBody CompositionNoninsulin Dependent Diabetes MellitusInsulin Dependent Diabetes MellitusHomeostasisHormone TherapyHypoglycemiaHypopituitarismInsulinLipid MetabolismLipolysisMedical ComplicationMetabolismMetforminNeuroendocrine SystemObesityPerformancePharmacokinetics
Grant awards (30)
HYPOPITUITARY CONTROL AND COMPLICATIONS STUDY (HYPOCCS-1)$0
M01 · FY2002 · RR
ACUTE METABOLIC CONTROL &EXERCISE PERFORMANCE IN IDDM$0
M01 · FY2002 · RR
COMP INCREMENTAL WEIGHT BASED DOSE REGIMEN W/ INDIVIDUALIZED DOSE$0
M01 · FY2002 · RR
METABOLIC ADAPTIONS TO DIABETES$0
M01 · FY2002 · RR
REGULATION OF FAT METABOLISM DURING EXERCISE$0
M01 · FY2002 · RR
HUMAN INSULIN LIKE GROWTH FACTOR 1 FOR TREATMENT OF TYPE II DIABETES MELLITUS$0
M01 · FY2002 · RR
HYPOPITUITARY CONTROL AND COMPLICATIONS STUDY (HYPOCCS-1)$0
M01 · FY2001 · RR
ACUTE METABOLIC CONTROL &EXERCISE PERFORMANCE IN IDDM$0
M01 · FY2001 · RR
ACUTE METABOLIC CONTROL &EXERCISE PERFORMANCE IN IDDM$0
M01 · FY2001 · RR
ACUTE METABOLIC CONTROL &EXERCISE PERFORMANCE IN IDDM$0
M01 · FY2001 · RR
HUMAN INSULIN LIKE GROWTH FACTOR 1 FOR TREATMENT OF TYPE II DIABETES MELLITUS$0
M01 · FY2001 · RR
HUMAN INSULIN LIKE GROWTH FACTOR 1 FOR TREATMENT OF TYPE II DIABETES MELLITUS$0
M01 · FY2001 · RR
METABOLIC ADAPTIONS TO DIABETES$0
M01 · FY2001 · RR
COMP INCREMENTAL WEIGHT BASED DOSE REGIMEN W/ INDIVIDUALIZED DOSE$0
M01 · FY2001 · RR
REGULATION OF FAT METABOLISM DURING EXERCISE$0
M01 · FY2001 · RR
REGULATION OF FAT METABOLISM DURING EXERCISE$0
M01 · FY2001 · RR
REGULATION OF FAT METABOLISM DURING EXERCISE$0
M01 · FY2001 · RR
HYPOPITUITARY CONTROL AND COMPLICATIONS STUDY (HYPOCCS-1)$0
M01 · FY2001 · RR
HYPOPITUITARY CONTROL AND COMPLICATIONS STUDY (HYPOCCS-1)$0
M01 · FY2001 · RR
COMP INCREMENTAL WEIGHT BASED DOSE REGIMEN W/ INDIVIDUALIZED DOSE$0
M01 · FY2001 · RR
METABOLIC ADAPTIONS TO DIABETES$0
M01 · FY2001 · RR
HUMAN INSULIN LIKE GROWTH FACTOR 1 FOR TREATMENT OF TYPE II DIABETES MELLITUS$0
M01 · FY2001 · RR
METABOLIC ADAPTIONS TO DIABETES$0
M01 · FY2001 · RR
COMP INCREMENTAL WEIGHT BASED DOSE REGIMEN W/ INDIVIDUALIZED DOSE$0
M01 · FY2001 · RR
ACUTE METABOLIC CONTROL &EXERCISE PERFORMANCE IN IDDM$592
M01 · FY2000 · RR
HUMAN INSULIN LIKE GROWTH FACTOR 1 FOR TREATMENT OF TYPE II DIABETES MELLITUS$0
M01 · FY2000 · RR
HYPOPITUITARY CONTROL AND COMPLICATIONS STUDY (HYPOCCS-1)$0
M01 · FY2000 · RR
COMP INCREMENTAL WEIGHT BASED DOSE REGIMEN W/ INDIVIDUALIZED DOSE$0
M01 · FY2000 · RR
REGULATION OF FAT METABOLISM DURING EXERCISE$0
M01 · FY2000 · RR
METABOLIC ADAPTIONS TO DIABETES$0
M01 · FY2000 · RR